Ma's comprehensive research results show that the combination of SHR-1210 and chemotherapy in the first-line treatment of advanced squamous cell carcinoma can reduce the levels of serum SCC and VEGF. The gene discussed is SERPINB3; the disease is squamous cell carcinoma.